Zobrazeno 1 - 10
of 1 258
pro vyhledávání: '"Tobinai, K"'
Autor:
Horwitz, S., O'Connor, O.A., Pro, B., Trümper, L., Iyer, S., Advani, R., Bartlett, N.L., Christensen, J.H., Morschhauser, F., Domingo-Domenech, E., Rossi, G., Kim, W.S., Feldman, T., Menne, T., Belada, D., Illés, Á., Tobinai, K., Tsukasaki, K., Yeh, S.-P., Shustov, A., Hüttmann, A., Savage, K.J., Yuen, S., Zinzani, P.L., Miao, H., Bunn, V., Fenton, K., Fanale, M., Puhlmann, M., Illidge, T.
Publikováno v:
In Annals of Oncology March 2022 33(3):288-298
Autor:
Witzig, T.E. *, Tobinai, K., Rigacci, L., Ikeda, T., Vanazzi, A., Hino, M., Shi, Y., Mayer, J., Costa, L.J., Bermudez Silva, C.D., Zhu, J., Belada, D., Bouabdallah, K., Kattan, J.G., Kuruvilla, J., Kim, W.S., Larouche, J.-F., Ogura, M., Ozcan, M., Fayad, L., Wu, C., Fan, J., Louveau, A.-L., Voi, M., Cavalli, F.
Publikováno v:
In Annals of Oncology March 2018 29(3):707-714
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Shustov, A., Cabrera, M. E., Civallero, M., Bellei, M., Y. H., Ko, Manni, M., Skrypets, T., Horwitz, S. M., de Souza, C. A., Radford, J. A., Bobillo, S., Prates, M. V., Ferreri, A. J. M., Chiattone, C., Spina, M., Vose, J. M., Chiappella, A., Laszlo, D., Marino, D., Stelitano, C., Federico, M., Savage, K., Connors, J., Gascoyne, R., Chhanabhai, M., Wilson, W., Jaffe, E. S., Armitage, J. O., Weisenburger, D. D., Anderson, J., Ullrich, F., Bast, M., Hochberg, E., Harris, N., Smogorzews ka, A., Levine, A., Nathwani, B. N., Miller, T., Rimsza, L., Montserrat, E., Lopez-Guillermo, A., Campo, E., Cuadros, M., Ferreira, J. A., Delgado, B. M., Holte, H., Delabie, J., Rudiger, T., Muller-Hermelink, K., Reimer, P., Adam, P., Wilhelm, M., Schmitz, N., Nerl, C., Lister, A., Norton, A., Maclennan, K. A., Zinzani, P. L., Pileri, S. A., Bellai, M., Luminari, S., Coiffier, B., Berger, F., Tanin, I., Wannakrairot, P., W. Y., Au, Liang, R., Loong, F., Rajan, S., Sng, I., Tobinai, K., Matsuno, Y., Morishima, Y., Nakamura, S., Seto, M., Tanimoto, M., Yoshino, T., Suzumiya, J., Ohshima, K., Kim, W. -S.
Publikováno v:
Shustov, A, Cabrera, M E, Civallero, M, Hyeh Ko, Y, Manni, M, Skrypets, T, Horwitz, S M, de Souza, C A, Radford, J, Bobillo, S, Prates, M V, Ferreri, A J M, Spina, M, Vose, J M, Chiappella, A, Laszlo, D, Stelitano, C & Frederico, M 2021, ' ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project ', Blood Advances, vol. 5, no. 3, 3, pp. 640-648 . https://doi.org/10.1182/bloodadvances.2020001581
Blood Adv
Blood Adv
Anaplastic lymphoma kinase–negative anaplastic large cell lymphoma (ALK– ALCL) is an aggressive neoplasm of T-cell/null-cell lineage. The T-Cell Project is a global prospective cohort study that consecutively enrolled patients newly diagnosed wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77d8ff357df1d67aa6e5469dd7bc4930
https://doi.org/10.1182/bloodadvances.2020001581
https://doi.org/10.1182/bloodadvances.2020001581
Autor:
Horwitz, S, O'Connor, O A, Pro, B, Trümper, L, Iyer, S, Advani, R, Bartlett, N L, Christensen, J H, Morschhauser, F, Domingo-Domenech, E, Rossi, G, Kim, W S, Feldman, T, Menne, T, Belada, D, Illés, Á, Tobinai, K, Tsukasaki, K, Yeh, S-P, Shustov, A, Hüttmann, A, Savage, K J, Yuen, S, Zinzani, P L, Miao, H, Bunn, V, Fenton, K, Fanale, M, Puhlmann, M, Illidge, T
Publikováno v:
Horwitz, S, O'Connor, O A, Pro, B, Trümper, L, Iyer, S, Advani, R, Bartlett, N L, Christensen, J H, Morschhauser, F, Domingo-Domenech, E, Rossi, G, Kim, W S, Feldman, T, Menne, T, Belada, D, Illés, Á, Tobinai, K, Tsukasaki, K, Yeh, S-P, Shustov, A, Hüttmann, A, Savage, K J, Yuen, S, Zinzani, P L, Miao, H, Bunn, V, Fenton, K, Fanale, M, Puhlmann, M & Illidge, T 2022, ' The ECHELON-2 Trial : 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma ', Annals of Oncology, vol. 33, no. 3, pp. 288-298 . https://doi.org/10.1016/j.annonc.2021.12.002
Horwitz, S, O'Connor, O A, Pro, B, Trümper, L, Iyer, S, Advani, R, Bartlett, N L, Christensen, J H, Morschhauser, F, Domingo-Domenech, E, Rossi, G, Kim, W S, Feldman, T, Menne, T, Belada, D, Illés, Á, Tobinai, K, Tsukasaki, K, Yeh, S-P, Shustov, A, Hüttmann, A, Savage, K J, Yuen, S, Zinzani, P L, Miao, H, Bunn, V, Fenton, K, Fanale, M, Puhlmann, M & Illidge, T 2021, ' The ECHELON-2 Trial : 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma ', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 33, no. 3, pp. 288-298 . https://doi.org/10.1016/j.annonc.2021.12.002
Horwitz, S, O'Connor, O A, Pro, B, Trümper, L, Iyer, S, Advani, R, Bartlett, N L, Christensen, J H, Morschhauser, F, Domingo-Domenech, E, Rossi, G, Kim, W S, Feldman, T, Menne, T, Belada, D, Illés, Á, Tobinai, K, Tsukasaki, K, Yeh, S-P, Shustov, A, Hüttmann, A, Savage, K J, Yuen, S, Zinzani, P L, Miao, H, Bunn, V, Fenton, K, Fanale, M, Puhlmann, M & Illidge, T 2021, ' The ECHELON-2 Trial : 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma ', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 33, no. 3, pp. 288-298 . https://doi.org/10.1016/j.annonc.2021.12.002
BACKGROUND: For patients with peripheral T-cell lymphoma (PTCL), outcomes using frontline treatment with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP-like therapy are typically poor. The ECHELON-2 study demonstrated that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b3bfa6d1173b5676a4c251f8a185f45
https://findresearcher.sdu.dk:8443/ws/files/199229320/1_s2.0_S0923753421048754_main.pdf
https://findresearcher.sdu.dk:8443/ws/files/199229320/1_s2.0_S0923753421048754_main.pdf
Publikováno v:
OncoTargets and Therapy, Vol Volume 13, Pp 5993-6009 (2020)
Shinichi Makita, Dai Maruyama, Kensei Tobinai Department of Hematology, National Cancer Center Hospital, Tokyo, JapanCorrespondence: Shinichi MakitaDepartment of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo 104-0045, Jap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::551c5a20ac1d28e28b3678b081272f86
https://www.dovepress.com/safety-and-efficacy-of-brentuximab-vedotin-in-the-treatment-of-classic-peer-reviewed-article-OTT
https://www.dovepress.com/safety-and-efficacy-of-brentuximab-vedotin-in-the-treatment-of-classic-peer-reviewed-article-OTT
Autor:
Ohmachi, K. *, Tobinai, K., Kobayashi, Y., Itoh, K., Nakata, M., Shibata, T., Morishima, Y., Ogura, M., Suzuki, T., Ueda, R., Aikawa, K., Nakamura, S., Fukuda, H., Shimoyama, M., Hotta, T.
Publikováno v:
In Annals of Oncology June 2011 22(6):1382-1391
Autor:
Zinzani, P. L., Illidge, T., Horwitz, S. M., O'Connor, O. A., Pro, B., Iyer, S. P., Advani, R., Bartlett, N. L., Christensen, J. H., Morschhauser, F., Domingo-Domenech, E., Rossi, G., Kim, W. S., Feldman, T. A., Menne, T., Belada, D., Illes, A., Tobinai, K., Tsukasaki, K., Yeh, S-P., Huttmann, A., Savage, K. J., Yuen, S., Miao, H., Bunn, V., Fenton, K., Fanale, M. A., Puhlmann, M., Trumper, L.
Publikováno v:
Zinzani, P L, Illidge, T, Horwitz, S M, O'Connor, O A, Pro, B, Iyer, S P, Advani, R, Bartlett, N L, Christensen, J H, Morschhauser, F, Domingo-Domenech, E, Rossi, G, Kim, W S, Feldman, T A, Menne, T, Belada, D, Illes, A, Tobinai, K, Tsukasaki, K, Yeh, S-P, Huttmann, A, Savage, K J, Yuen, S, Miao, H, Bunn, V, Fenton, K, Fanale, M A, Puhlmann, M & Trumper, L 2021, ' ECHELON-2 (NCT01777152), A RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF BRENTUXIMAB VEDOTIN plus CHP VS CHOP IN PREVIOUSLY UNTREATED PATIENTS WITH CD30-POSITIVE PERIPHERAL T-CELL LYMPHOMA: 5-YEAR RESULTS ', Haematologica, vol. 106, no. 10, Suppl. 3, pp. 3 . < https://doi.org/10.3324/haematol.2021.s3 >
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3062::f0965bd430d8c8753ef8c4c900cf6c95
https://portal.findresearcher.sdu.dk/da/publications/d13b2c46-5c6b-482c-b508-9f2b755dfe65
https://portal.findresearcher.sdu.dk/da/publications/d13b2c46-5c6b-482c-b508-9f2b755dfe65
Autor:
Mori, M., Kobayashi, Y. *, Maeshima, A.M., Gotoda, T., Oda, I., Kagami, Y., Bennett, S., Nomoto, J., Azuma, T., Yokoyama, H., Maruyama, D., Kim, S.-W., Watanabe, T., Matsuno, Y., Tobinai, K.
Publikováno v:
In Annals of Oncology July 2010 21(7):1500-1505